Evidence map›Paper›PMID 26008193›Full record

ArticleNanomedicine (London, England)2015

Metabolic and structural integrity of magnetic nanoparticle-loaded primary endothelial cells for targeted cell therapy.

Zulfiya Orynbayeva, Richard Sensenig, Boris Polyak

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Magnetic Cell Targeting for Cardiovascular Tissue Engineering.Tissue engineering. Part B, Reviews · 2025
    Review
  3. Article
  4. Magneto-Mechanical Actuation Induces Endothelial Permeability.ACS biomaterials science & engineering · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zulfiya Orynbayeva1Department of Surgery, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Richard Sensenig2Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
Boris Polyak1Department of Surgery, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

Funding

Magnetic Targeting Of Stents With Endothelial Cells For Prevention Of RestenosisR01HL107771 · NHLBI · DREXEL UNIVERSITY · PI POLYAK, BORIS · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL107771NHLBI NIH HHS R01HL107771
6 · The paper itself

Abstract

aimTo successfully translate magnetically mediated cell targeting from bench to bedside, there is a need to systematically assess the potential adverse effects of magnetic nanoparticles (MNPs) interacting with 'therapeutic' cells. Here, we examined in detail the effects of internalized polymeric MNPs on primary rat endothelial cells' structural intactness, metabolic integrity and proliferation potential. MATERIALS &

methodsThe intactness of cytoskeleton and organelles was studied by fluorescent confocal microscopy, flow cytometry and high-resolution respirometry.

resultsMNP-loaded primary endothelial cells preserve intact cytoskeleton and organelles, maintain normal rate of proliferation, calcium signaling and mitochondria energy metabolism.

conclusionThis study provides supportive evidence that MNPs at doses necessary for targeting did not induce significant adverse effects on structural integrity and functionality of primary endothelial cells - potential cell therapy vectors.

Indexed as

Cell- and Tissue-Based TherapyMagneticsNanoparticlesAnimalsCells, CulturedEndothelium, VascularRatsCa2+ signalingcytoskeletonmagnetic nanoparticlesmitochondria membrane potentialmitochondria oxidative phosphorylationprimary endothelial cells

Identifiers

PMID26008193
PMCPMC4464789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.